Generic drug and biosimilar companies support innovation in medicine to benefit patients. Brand name drug companies who abuse the patent system harm patients. See our amicus brief opposing the rental of Native American tribal sovereign immunity by a brand name pharmaceutical company to extend its drug patent monopoly and keep prices high.
